Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TSX is where you want to be for funds, banks, etc to buy up. Also we can become part of index funds that buy positions.
You are right but it was never widely communicated.
Hi I believe we can hit 20 when the time comes for management to set expectations for 2016. The irrational exuberance I showed via the graph will be responsible for taking us beyond..
The article this image was taken from, is at this link. Is one of my personal favourites.
http://steveblank.com/2011/06/17/are-you-you-the-fool-at-the-table/
Everything sounds logical but I prefer to analyze it from a market perspective.
If even 100 devices are sold in 2015, at a LOW 5x sales multiple (do some DD, explosive growth companies command much higher multiples earlier on), that's $500MM market cap or $5 per share assuming current share count the day the estimate comes out, not the actual sales (thinking Q1/Q2 2015)
In 2016 if 250 devices are sold and serviced, that's now closing in on 1.5BN market cap or $15 per share at the same low 5x sales, again, based on estimates not sales (target Q4 2015)
Given we're somewhere in the stealth to awareness phase of this stock (I think it started last fall), and mix in some emotions, we could see $20 before 2016.
Refer to this chart for some education on how these usually work, and even take DDD as a recent example of stock market runups.
http://steveblank.files.wordpress.com/2011/06/bubble-phases.jpg
Based on his timing related to Sport he left before the alpha unit was finalized. There's lots of detail between alpha and design freeze he wouldn't be aware of. Anything he does know I'm comfortable is not a game breaker at this stage. IMHO
Should however it is not public knowledge yet. Let's see how this reacts once it is public.
I'm curious to know what is the new responsibility in this new role vs when he was just director? Or does it clear way for the hiring of a larger team from a hierarchy perspectice?
Technology consultant from Toronto is my answer.
I'm sure it's not with himself. On a side note, did you know that this site had only 300 messages for the first 3 years of TITXF (since 2010), and now explosive messaging in the past year? Word seems to be spreading..
I'm relatively new on this board and I like posilock but you can create two accounts.
My thinking on pricing is they should half price of a davinci so hospitals can get two sports (mobile devices) or one massive davinci that's stuck in a room. So 800k resonates for me
Very much looking forward to next week then..
I asked my friends in banking on this one, and they always calculate enterprise valuation (buyout value) as a total number (ie: $2 billion) vs. a PPS. They then calculate the per share price by taking the enterprise value and dividing by shares outstanding to get the buyout price per share.
Given this, there is no big deal on PPS and number of shares from a buyout perspective.
I agree also.. 100MM shares, even with future warrant exercising taking it up 10% or so, is not a horrible #. I've seen other development phase companies have many 100's of millions of shares.
I could see a sceniaro where TITXF has a market cap of $400-500MM after CE mark early next spring is not unreasonable. That's about a $5 stock price and then the opportunity to uplist starts.
Wouldn't that vendor be Ximedica?
I really like the milestone breakdown with associated costs.. Looks like end of 2015 for US launch!
May not all happen on Monday but a run up after breaking all time high could be a fast and furious couple of days. I would be worried about a short term pump and dump. Refer to AAPL or DDD runups as examples of larger stocks where buyers get in late and then need to hold for a year or longer after the pump ends (and drop happens) to break even. At this point it's all hard to say but going up seems certain.
For twitter on TITXF try this link.. Looks like the word is $3 on Monday.
http://www.boardcentral.com/twitter/TITXF
I for one am ok with company valuation, it is nearing 200 million market cap, but sadly at the expense of PPS due to massive dilution this past year raising funds. I could also see it being at 800 million early next year which would be 8 dollar per share after CE approval. Once sales estimates come in we will be priced at the net present value of those sales so I could see 2 billion market cap by early 2016 based on 1 billion for 10x sales of 100 million or simply 50 devices and services and parts replacement based on AGM figures in Europe plus factor FDA approval for another billion hence 20 dollar PPS early 2016
Cool I was right beside him then.. So were you front row on the other side??
Hey - so in this article, there is a small piece of confirmation to the question from the Annual Meeting.
It was discussed if the daVinci SP would be sold alone, or part of the bigger XI tool. This now confirms that it won't be sold alone, and instead, is a bolt-on.
Therefore the price advantage of Titan still stands.
Quote:
"The company stated in its Q1 earnings call that it does not intend to commercialize the da Vinci Sp system and it would be sold as part of the da Vinci Xi system. Although these products are expected to gain acceptance in the market gradually, we expect them to significantly contribute to sales in the next few years."
Wow photographic memory ?? Good job on the notes I felt like I was there again. Btw I was next to your friend is he a broker or represents an institution ??
Something to think about - it may be the CEO people were pressuring for more PR's, but they hired Brooks to handle this for them.. Maybe we should be directing our questions to this corp (her) as well?
http://finance.yahoo.com/news/titan-medical-inc-retains-brooks-212959769.html
My two cents on this is that as a good CEO, he has a strong team surrounding him. He'll be fine
Sorry for missing, the term used was clinical trials
PS - I like the energy Joseph Talarico brought to the team.
I agree with your statement, I took away a lot of notes, and here are a couple of the "carrots" I left with;
- 30 months of funding
- 1 year away from trials
- 40 employees at ximedica working on this product
- 20 + medical experts say the video is better than state of art
- John currently talking about partnerships/sales in Europe
- CFO - $650k monthly burn rate
- CFO - Upto $80MM in Warrant funding to fund sales and post commercialization.
My opinions:
1) 50 million warrants though could dilute and not cause PPS appreciation like we expect
2) Mgmt is now less focused on PPS and more focused on product (I'm okay with this)
3) No Reverse Split (they didn't know what it was or why they would do it) - also no thinking currently of Nasdaq uplift.
Overall I would call this a Hold/Buy, as in, hold and buy more on dips. I can see this being a $800MM dollar company next year at the same time, and with say 120mm shares outstanding, that's about $6-$7 per share.
OK - I'll head over for 2pm tmrw at Scotia Plaza and take some notes and report back..
Thanks CUIN2 - I'm thinking I should take advantage of being a local and go to the meeting tomorrow!
New investor to board, thought I'd say hi. Been lurking for the past month and like the details some people bring up for discussion. All the best, let's hope for a bit more clarity on building up human capital prior to launch (that's my big sticky point right now, as the tech seems to be moving just fine)